DDMAC STEPPED UP ENFORCEMENT THROUGH WARNING LETTERS IN 2003

Drug Industry Daily
KEYWORDS Advertising / FDA / Warning
A A

Indicating a shift toward a tougher enforcement strategy, the percentage of warning letters issued by the FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) for misleading ad practices jumped dramatically in 2003 compared to the percentage of warning letters issued by the division in previous years.

To View This Article:

Login

Subscribe To Drug Industry Daily